New process for the synthesis of imidazo[4,5‐ b ]pyridine derivatives as potent orally active thromboxane a 2  receptor antagonists | Zendy

Nicolaï E. | Zendy; Claude S. | Zendy; Teulon J. M. | Zendy

Premium

New process for the synthesis of imidazo[4,5‐ b ]pyridine derivatives as potent orally active thromboxane a 2 receptor antagonists

Author(s) -

Nicolaï E.,

Claude S.,

Teulon J. M.

Publication year - 1994

Publication title -

journal of heterocyclic chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.321

H-Index - 59

eISSN - 1943-5193

pISSN - 0022-152X

DOI - 10.1002/jhet.5570310113

Subject(s) - chemistry , orally active , pyridine , antagonist , acetic anhydride , combinatorial chemistry , acetic acid , bicyclic molecule , stereochemistry , receptor antagonist , receptor , medicinal chemistry , organic chemistry , in vitro , biochemistry , catalysis

A new synthetic route to prepare the 4‐[3‐(4‐chlorophenyl)methyl‐6‐chloroimidazo[4,5‐ b ]pyridin‐2‐yl]‐3,3‐dimethylbutanoic acid (UP 116‐77) is described. UP 116‐77 is a potent orally active TXA 2 /PGH 2 receptor antagonist currently under pharmacological investigation. Its development needed a suitable synthesis for industrial processing. The cyclization of 3‐amino‐5‐chloro‐2‐(4‐chlorophenyl)methylaminopyridine 4 with 3,3‐dimethylglutaric anhydride in refluxing acetic acid affords a new efficient and simple way to UP 116‐77 and subsequently to various 2‐substituted imidazo[4,5‐ b ]pyridine derivatives.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research